WEREWOLF THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
WEREWOLF THERAPEUTICS, INC. (HOWL) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $2.00 million as of 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-09-22
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.00M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.60M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $5.40M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $6.60M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $2.00M S-4 · filed 2026-09-22 |
| 2026-03-31 | $2.60M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $5.40M S-4 · filed 2026-09-22 |
| 2025-09-30 | $6.60M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $8.20M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $9.80M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $8.90M 10-K · filed 2025-03-11 |
| 2024-09-30 | $10.60M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $12.40M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $14.10M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $9.90M 10-K · filed 2024-03-07 |
| 2023-09-30 | $11.20M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $16.90M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $18.60M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $18.30M 10-K · filed 2023-03-23 |
| 2022-09-30 | $20.20M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $18.80M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $20.00M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $14.80M 10-K · filed 2022-03-24 |
| 2021-09-30 | $15.50M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $11.20M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $6.20M 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |